Literature DB >> 15165903

ABCG2 -- a transporter for all seasons.

Balázs Sarkadi1, Csilla Ozvegy-Laczka, Katalin Német, András Váradi.   

Abstract

The human ABCG2 (ABCP/MXR/BCRP) protein is a recently recognized ABC half-transporter, which forms homodimers in the plasma membrane and actively extrudes a wide variety of chemically unrelated compounds from the cells. This protein protects our cells and tissues against various xenobiotics, with a crucial role in the intestine, liver, placenta, and the blood-brain barrier. Moreover, ABCG2 seems to have a key function in stem cell protection/regulation, and also in hypoxic defense mechanisms. Widely occurring single nucleotide polymorphisms in ABCG2 may affect absorption and distribution, altering the effectiveness and toxicity of drugs in large populations. At the clinics, overexpression of ABCG2 in tumor cells confers cancer multidrug resistance to a variety of newly developed anticancer agents. On the other hand, specific substrate mutants of ABCG2 are advocated for use as selectable markers in stem-cell based gene therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165903     DOI: 10.1016/j.febslet.2004.03.123

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  64 in total

Review 1.  Pharmacogenomics of the human ABC transporter ABCG2: from functional evaluation to drug molecular design.

Authors:  Toshihisa Ishikawa; Ai Tamura; Hikaru Saito; Kanako Wakabayashi; Hiroshi Nakagawa
Journal:  Naturwissenschaften       Date:  2005-10

Review 2.  Embryo stability and vulnerability in an always changing world.

Authors:  Amro Hamdoun; David Epel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

3.  Identification of a retroviral receptor used by an envelope protein derived by peptide library screening.

Authors:  Anindita Sarangi; Keith Bupp; Monica J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

4.  The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.

Authors:  Yuan Yuan; Zhulin Yang; Xiongying Miao; Daiqiang Li; Ziru Liu; Qiong Zou
Journal:  Tumour Biol       Date:  2015-07-16

Review 5.  The systems biology of uric acid transporters: the role of remote sensing and signaling.

Authors:  Sanjay K Nigam; Vibha Bhatnagar
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-07       Impact factor: 2.894

Review 6.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

7.  The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer.

Authors:  Beiqin Yu; Dongsheng Gu; Xiaoli Zhang; Bingya Liu; Jingwu Xie
Journal:  J Genet Genomics       Date:  2017-07-25       Impact factor: 4.275

8.  Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.

Authors:  Eran E Bram; Michal Stark; Shachar Raz; Yehuda G Assaraf
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

9.  A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.

Authors:  J Sun; M Zhu; W Shen; C Wang; J Dai; L Xu; G Jin; Z Hu; H Ma; H Shen
Journal:  Pharmacogenomics J       Date:  2016-03-08       Impact factor: 3.550

10.  Degradation or excretion of quantum dots in mouse embryonic stem cells.

Authors:  Qing Meng Pi; Wen Jie Zhang; Guang Dong Zhou; Wei Liu; Yilin Cao
Journal:  BMC Biotechnol       Date:  2010-05-06       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.